Literature DB >> 29087518

Diagnosis of aspergillosis by PCR: Clinical considerations and technical tips.

Rosemary A Barnes1, P Lewis White2, C Oliver Morton3, Thomas R Rogers4, Mario Cruciani5, Juergen Loeffler6, J Peter Donnelly7.   

Abstract

Standardization of Aspergillus polymerase chain reaction (PCR) protocols has progressed, and analytical validity of blood-based assays has been formally established. It remains necessary to consider how the tests can be used in practice to maximize clinical utility. To determine the optimal diagnostic strategies and influence on patient management, several factors require consideration, including the patient population, incidence of invasive aspergillosis (and other fungal disease), and the local antifungal prescribing policy. Technical issues such as specimen type, ease of sampling, frequency of testing, access to testing centers, and time to reporting will also influence the use of PCR in clinical practice. Interpretation of all diagnostic tests is dependent on the clinical context and molecular assays are no exception, but with the proposal to incorporate Aspergillus PCR into the second revision of the consensus guidelines for defining invasive fungal disease the acceptance and understanding of molecular tests should improve.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29087518     DOI: 10.1093/mmy/myx091

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  20 in total

1.  Invasive Fungal Infection.

Authors:  Marie von Lilienfeld-Toal; Johannes Wagener; Hermann Einsele; Oliver A Cornely; Oliver Kurzai
Journal:  Dtsch Arztebl Int       Date:  2019-04-19       Impact factor: 5.594

2.  Fungal immunology in clinical practice: Magical realism or practical reality?

Authors:  Christina C Chang; Stuart M Levitz
Journal:  Med Mycol       Date:  2019-06-01       Impact factor: 4.076

Review 3.  Aspergillus fumigatus and Aspergillosis in 2019.

Authors:  Jean-Paul Latgé; Georgios Chamilos
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

4.  Clinical Characteristics, Health Care Utilization, and Outcomes Among Patients in a Pilot Surveillance System for Invasive Mold Disease-Georgia, United States, 2017-2019.

Authors:  Jeremy A W Gold; Andrew Revis; Stepy Thomas; Lewis Perry; Rebekah A Blakney; Taylor Chambers; Meghan L Bentz; Elizabeth L Berkow; Shawn R Lockhart; Colleen Lysen; Natalie S Nunnally; Alexander Jordan; Hilary C Kelly; Alejandro J Montero; Monica M Farley; Nora T Oliver; Stephanie M Pouch; Andrew S Webster; Brendan R Jackson; Karlyn D Beer
Journal:  Open Forum Infect Dis       Date:  2022-04-21       Impact factor: 4.423

5.  A New and Highly Sensitive Serum Mannoprotein Lateral Flow Assay for Point-of-Care Diagnosis of Invasive Aspergillosis (Tripathy Method).

Authors:  Chandra P Chaturvedi; Zia Hashim; Naresh K Tripathy
Journal:  Cureus       Date:  2022-06-17

6.  How Long Do We Need to Treat an Invasive Mold Disease in Hematology Patients? Factors Influencing Duration of Therapy and Future Questions.

Authors:  Ana Fernández-Cruz; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

7.  Recognition of Diagnostic Gaps for Laboratory Diagnosis of Fungal Diseases: Expert Opinion from the Fungal Diagnostics Laboratories Consortium (FDLC).

Authors:  Sean X Zhang; N Esther Babady; Kimberly E Hanson; Amanda T Harrington; Paige M K Larkin; Sixto M Leal; Paul M Luethy; Isabella W Martin; Preeti Pancholi; Gary W Procop; Stefan Riedel; Seyedmojtaba Seyedmousavi; Kaede V Sullivan; Thomas J Walsh; Shawn R Lockhart
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

8.  Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.

Authors:  Mario Cruciani; Carlo Mengoli; Rosemary Barnes; J Peter Donnelly; Juergen Loeffler; Brian L Jones; Lena Klingspor; Johan Maertens; Charles O Morton; Lewis P White
Journal:  Cochrane Database Syst Rev       Date:  2019-09-03

9.  Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis.

Authors:  Darius Armstrong-James; Jonathan Youngs; Tihana Bicanic; Alireza Abdolrasouli; David W Denning; Elizabeth Johnson; Varun Mehra; Tony Pagliuca; Brijesh Patel; Johanna Rhodes; Silke Schelenz; Anand Shah; Frank L van de Veerdonk; Paul E Verweij; P Lewis White; Matthew C Fisher
Journal:  Eur Respir J       Date:  2020-10-01       Impact factor: 16.671

10.  Genotyping of Aspergillus fumigatus in Formalin-Fixed Paraffin-Embedded Tissues and Serum Samples From Patients With Invasive Aspergillosis.

Authors:  Theun de Groot; Ferry Hagen; Willem Vreuls; Paul E Verweij; Anuradha Chowdhary; Jacques F Meis
Journal:  Front Cell Infect Microbiol       Date:  2018-10-23       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.